US EditionPublished • loading... • Updated
NH Among States Retreating From Covering Drugs for Weight Loss
States cite budget pressures and high drug costs for ending or restricting Medicaid coverage of GLP-1 weight-loss medications amid rising demand and spending, KFF reported.
- Many states are reconsidering their coverage of GLP-1 drugs for weight loss due to budget constraints, as noted in President Donald Trump’s tax and spending law.
- Some states will stop covering or restrict eligibility for these drugs, with North Carolina Medicaid recently ending coverage.
- California, New Hampshire, and South Carolina plan to discontinue coverage on January 1, reflecting their budget challenges.
- Doctors and patient advocates argue that GLP-1 drugs could reduce costs by preventing obesity-related diseases.
Insights by Ground AI
33 Articles
33 Articles
States retreat from covering drugs for weight loss
Some states are rethinking their coverage of GLP-1 drugs for weight loss as budgets tighten and Medicaid programs brace for the cuts included in President Donald Trump’s broad tax and spending law. Read more...
·Vancouver, United States
Read Full Article
Firm Tied To Kristi Noem Secretly Got Money From $220 Million DHS Ad Contracts
This story was originally published by ProPublica. Republished under a CC BY-NC-ND 3.0 license. On Oct. 2, the second day of the government shutdown, Homeland Security Secretary Kristi Noem arrived at Mount Rushmore to shoot a television ad. Sitting on horseback in chaps and a cowboy hat, Noem addressed the camera with a stern message for immigrants: “Break our laws,…
Coverage Details
Total News Sources33
Leaning Left23Leaning Right0Center5Last UpdatedBias Distribution82% Left
Bias Distribution
- 82% of the sources lean Left
82% Left
L 82%
C 18%
Factuality
To view factuality data please Upgrade to Premium
